The Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019

The Animals and Animal Products (Examination for Residues and Maximum Residue Limits) (England and Scotland) Regulations 2015 U.K.

4.—(1) The Animals and Animal Products (Examination for Residues and Maximum Residue Limits) (England and Scotland) Regulations 2015 M1 are amended as follows.

(2) In regulation 2(1)—

(a) omit the definition for “Regulation 37/2010”;

(b) for the definition of “Table 1” (including the definition of “Table 1 substance”) substitute—

““Table 1 substance” means a substance classified under Article 14(2)(a), (b) or (c) of Regulation 470/2009;”;

(c) for the definition of “Table 2 substance” substitute—

““Table 2 substance” means a substance classified under Article 14(2)(d) of Regulation 470/2009;”;

(d) in the definition of “unauthorised substance”, for “EU legislation” substitute “ retained EU law ”;

(e) for the definition of “unlicensed substance” substitute—

““unlicensed substance” means a substance—

(a) for which a maximum residue limit has been established under Regulation 470/2009, and

(b) which has been—

(i) administered (or is intended for administration) in the United Kingdom to an animal or a batch of animals, or

(ii) administered to an animal outside the United Kingdom,

where at the time of administration neither that substance, nor any product containing it, was authorised for use in that animal in that country of administration;”.

(3) For regulation 2(2) substitute—

“(2) For the purpose of ascertaining whether the maximum residue limit established for a pharmacologically active substance has been exceeded for the purposes of these Regulations—

(a) the presence of the drug or drug metabolite (or combination thereof) as specified in the marker residue for that pharmacologically active substance is to be taken to indicate the presence of that substance in that part of an animal or batch of animals, or in any animal product derived from that part of an animal or batch of animals, as specified in the target tissues for that substance;

(b) the maximum residue limit (if any) corresponding to that substance is to apply in respect of the presence in such part of an animal or batch of animals, or in any animal product derived from such part of an animal or batch of animals, of any such drug or drug metabolite (or combination thereof) as if it were that substance.”.

(4) In regulation 2(4)—

(a) for “96/22,” substitute “ 96/22 or ”;

(b) omit “or Regulation 37/2010”.

Commencement Information

I1 Reg. 4 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)(b)

Marginal Citations

M1 S.I. 2015/787.